|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 78.35 CHF | -0.19% |
|
+1.88% | +5.45% |
| Oct. 25 | GALENICA : Multiple positives in a strong Q3 24 update |  |
| Oct. 24 | Busy Earnings Day Boosts Swiss Stocks | MT |
| Capitalization | 3.91B 4.31B 4.14B 3.5B 6.17B 371B 6.88B 47.53B 17.61B 153B 16.16B 15.83B 671B | P/E ratio 2024 * |
23.3x | P/E ratio 2025 * | 21.3x |
|---|---|---|---|---|---|
| Enterprise value | 4.49B 4.95B 4.76B 4.02B 7.08B 426B 7.9B 54.55B 20.22B 176B 18.55B 18.17B 770B | EV / Sales 2024 * |
1.15x | EV / Sales 2025 * | 1.1x |
| Free-Float |
99.44% | Yield 2024 * |
2.86% | Yield 2025 * | 3.03% |
More valuation ratios
* Estimated data
More news
Last Transcript: Galenica AG
More recommendations
More press releases
More news
| 1 day | +0.76% | ||
| 1 week | +2.82% | ||
| Current month | +5.58% | ||
| 1 month | +7.68% | ||
| 3 months | +3.02% | ||
| 6 months | +4.60% | ||
| Current year | +5.58% |
1 week
76.80
78.80
1 month
72.1578.80
Current year
74.1078.80
1 year
69.3078.80
3 years
60.5582.20
5 years
57.1582.20
10 years
41.8082.20
| Director | Title | Age | Since |
|---|---|---|---|
Marc Werner
CEO | Chief Executive Officer | 58 | 2020-03-31 |
Lukas Ackermann
CTO | Chief Tech/Sci/R&D Officer | 53 | 2021-12-31 |
Marianne Hasler
HRO | Human Resources Officer | 46 | 2023-08-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 2016-12-31 | |
Bertrand Jungo
BRD | Director/Board Member | 60 | 2017-12-31 |
| Chairman | 67 | 2023-05-02 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.17% | 1,017 M€ | +0.63% | ||
| 0.02% | 0 M€ | -3.35% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.76% | +2.82% | +5.58% | +21.33% | 4.31B | ||
| -0.44% | +1.28% | +22.28% | +135.30% | 75.22B | ||
| -0.60% | +4.48% | +19.71% | +144.66% | 30.56B | ||
| +0.88% | -1.76% | +22.68% | -3.41% | 8.9B | ||
| +3.34% | +5.23% | -1.25% | -10.89% | 8.16B | ||
| +1.55% | +0.50% | +13.89% | +8.75% | 8B | ||
| -0.40% | +1.01% | +16.08% | - | 5.32B | ||
| -0.35% | +1.13% | +3.15% | -6.29% | 4.05B | ||
| 0.00% | +2.29% | -9.07% | -7.09% | 3.31B | ||
| -1.94% | +2.02% | +7.41% | +3.57% | 3.23B | ||
| Average | +0.28% | +1.14% | +10.05% | +31.77% | 15.11B | |
| Weighted average by Cap. | -0.07% | +1.86% | +17.86% | +100.20% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 3.9B 4.29B 4.13B 3.49B 6.15B 370B 6.85B 47.34B 17.54B 153B 16.1B 15.77B 668B | 4.07B 4.48B 4.31B 3.65B 6.42B 387B 7.16B 49.46B 18.33B 159B 16.82B 16.47B 698B |
| Net income | 172M 189M 182M 154M 271M 16.3B 302M 2.09B 773M 6.73B 709M 695M 29.44B | 180M 198M 191M 161M 284M 17.09B 317M 2.19B 810M 7.05B 744M 728M 30.87B |
| Net Debt | 578M 637M 612M 518M 912M 54.9B 1.02B 7.02B 2.6B 22.65B 2.39B 2.34B 99.13B | 553M 609M 585M 495M 872M 52.49B 972M 6.72B 2.49B 21.65B 2.28B 2.24B 94.78B |
More financial data
* Estimated data
Employees
7,955
Sector
Pharmaceuticals
Calendar
2025-01-20
- Q4 2024 Sales and Revenue Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-01-21 | 78.40 CHF | -0.13% | 4,862 |
| 25-01-20 | 78.50 CHF | +0.06% | 65,728 |
| 25-01-17 | 78.45 CHF | +0.38% | 62,896 |
| 25-01-16 | 78.15 CHF | +0.71% | 85,948 |
| 25-01-15 | 77.60 CHF | +0.84% | 98,168 |
Delayed Quote Swiss Exchange, January 20, 2025 at 11:30 am EST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
78.50CHF
Average target price
77.62CHF
Spread / Average Target
-1.11%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GALE Stock
